Thomas E. Keane
Medical University of South Carolina · 178 works · 5,839 citations · h-index 36
Top works
- A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma
- A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma
- Conservative management of perforated duodenal ulcer
- Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma
- Critical evaluation of hormonal therapy for carcinoma of the prostate
- Relationship of Cytokeratin 20 and CD44 Protein Expression with WHO/ISUP Grade in pTa and pT1 Papillary Urothelial Neoplasia
- LONG-TERM EFFICACY OF SILDENAFIL AND TACHYPHYLAXIS EFFECT
- Impotence following pelvic fracture urethral injury: incidence, aetiology and management
- Evaluation of staging lymphadenectomy in prostate cancer
- Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma
- Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial
- Partial segmental thrombosis of corpus cavernosum: Case report and review of world literature
- Challenges and Recommendations for Early Identification of Metastatic Disease in Prostate Cancer
- Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice
- GUNSHOT WOUNDS TO THE URETER: A 40-YEAR EXPERIENCE AT GRADY MEMORIAL HOSPITAL
- Preliminary treatment considerations among men with newly diagnosed prostate cancer.
- The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- pT1 Urothelial Carcinoma of the Bladder: Criteria for Diagnosis, Pitfalls, and Clinical Implications
- Serum Testosterone Recovery After Cessation of Long-Term Luteinizing Hormone-Releasing Hormone Agonist in Patients with Prostate Cancer
- A Clinician’s Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III)